A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Pamela Munster
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Pamela Munster
Professor, Medicine. Authored (or co-authored) 130 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Clovis Oncology, Inc.
- ID
- NCT04171700
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated